Oyama Jun-ichi, Nagatomo Daisuke, Yoshioka Goro, Yamasaki Ayumu, Kodama Kazuhisa, Sato Michio, Komoda Hiroshi, Nishikido Toshiyuki, Shiraki Aya, Node Koichi
Department of Advanced Cardiology, Saga University, Saga, Japan.
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
J Cardiol. 2016 Mar;67(3):295-302. doi: 10.1016/j.jjcc.2015.06.005. Epub 2015 Sep 4.
Obstructive sleep apnea (OSA) is characterized by repetitive intermittent hypoxia and reoxygenation during sleep with elevated oxidative stress and promotes the development of atherosclerosis, as demonstrated by vascular dysfunction and chronic inflammation. An increased neutrophil to lymphocyte ratio (NLR) has been recognized to be a novel inflammatory biomarker for systemic inflammation.
We evaluated whether the NLR reflects the severity of OSA and if continuous positive airway pressure (CPAP) treatment ameliorates the endothelial function and NLR in patients with OSA.
We enrolled 95 patients with suspected OSA and 29 patients who received CPAP therapy for 3 months. We evaluated the number of endothelial progenitor cells (EPCs) and NLR, the levels of nitric oxide (NOx) and asymmetric dimethylarginine (ADMA), and the endothelial function according to the flow-mediated dilatation (FMD) before and after CPAP treatment.
The levels of apnea-hypopnea index demonstrated an inverse relationship with the FMD and a positive relationship with the NLR. Moreover, NLR is an independent factor suggested for the presence of severe OSA. CPAP therapy increased the levels of EPC and NOx and decreased the level of ADMA. CPAP treatment also improved the FMD and decreased the NLR.
NLR and endothelial dysfunction significantly correlates with the severity of OSA and FMD and other biochemical parameters improved and NLR decreased significantly after CPAP treatment.
阻塞性睡眠呼吸暂停(OSA)的特征是睡眠期间反复出现间歇性缺氧和复氧,伴有氧化应激升高,并促进动脉粥样硬化的发展,血管功能障碍和慢性炎症已证实了这一点。中性粒细胞与淋巴细胞比值(NLR)升高已被认为是全身性炎症的一种新型炎症生物标志物。
我们评估了NLR是否反映OSA的严重程度,以及持续气道正压通气(CPAP)治疗是否能改善OSA患者的内皮功能和NLR。
我们纳入了95例疑似OSA患者和29例接受CPAP治疗3个月的患者。我们评估了CPAP治疗前后内皮祖细胞(EPCs)数量和NLR、一氧化氮(NOx)和不对称二甲基精氨酸(ADMA)水平,以及根据血流介导的扩张(FMD)评估的内皮功能。
呼吸暂停低通气指数水平与FMD呈负相关,与NLR呈正相关。此外,NLR是提示存在重度OSA的一个独立因素。CPAP治疗增加了EPC和NOx水平,降低了ADMA水平。CPAP治疗还改善了FMD并降低了NLR。
NLR和内皮功能障碍与OSA的严重程度显著相关,CPAP治疗后FMD和其他生化参数改善,NLR显著降低。